4/22/2025AZ's Ultomiris for Generalized Myasthenia Gravis in China

4/22/2025China Seeks Feedback on ICH Draft Guideline M13B for Biowaivers of Add...

4/22/2025Fosun Boosts Stake in Henlius After Failed Privatization Attempt

4/22/2025Fujifilm Capitalizes on U.S.-China Tensions with $3B Biopharma Deal

4/22/2025Carbogen Amcis Secures Chinese Drug Manufacturing License

4/19/2025HighTide's HTD1801 Meets Goals in Two Phase 3 Diabetes Trials

4/19/2025China Approves AstraZeneca's Truqap for Advanced HR+/HER2– Breast Can...

4/19/2025Akeso's Ebdarokimab Approved in China as First Domestic IL-12/IL-23 An...

4/19/2025Haleon Achieves Full Ownership of Tianjin SmithKline JV

4/19/2025China Issues New Guidelines to Streamline Mainland Registration for Or...

4/18/2025VelaVigo and Ollin Biosciences Ink ex-Greater China Licensing Deal for...

4/18/2025WuXi Biologics Completes 15,000L PPQ at Hangzhou Site

4/18/2025Chinese drugmakers weigh options as US mulls pharma tariffs (KrAsia)

4/17/2025This Pharma Company Is Betting Big On A Chinese Ozempic Rival (Forbes)

4/17/2025Interpretation of the Anti-Monopoly Guidelines for Pharmaceutical Sect...

4/17/2025BMS Launches Head-to-Head Phase 1 Trial for SystImmune-Licensed EGFR/H...

4/17/2025DualityBio Raises $211M in Hong Kong IPO

4/17/2025InnoCare's Zurletrectinib NDA Accepted by China's NMPA for NTRK Fusion...

4/17/2025Eli Lilly's Mirikizumab Advances in China with New Indication Filing

4/17/2025Akeso Advances Second ADC into Clinical Trials with TROP2/Nectin-4 Bis...

4/17/2025Sanofi Secures Global Rights to AI-Discovered BsAb in $1.8B+ Deal with...

4/17/2025Hengrui Advances CD79b-Targeted ADC SHR-A1912 into Phase 3 Trial for R...

4/17/2025Latticon Pioneers China's First Pipeline-Backed Financing Deal

4/17/2025Eddingpharm to Take Over Genor in HKEX's First 18A Reverse Merger

4/17/2025WuXi AppTec Cashes Out of WuXi XDC as U.S. Tariff Threats Mount

4/17/2025Pharma Giants Already Moving to Cut Reliance on China Amid Tariff Unce...

4/15/2025Gardasil9 Gains Expanded Approval in China

4/15/2025China NMPA Approves Kowa's Parmodia (Pemafibrate) for Dyslipidemia Tre...

4/15/2025Chinese Pharma Companies Rethink Global Strategies as US Considers Dru...

4/15/2025U.S. Tariff Threat on Chinese Pharma Could Reshape Landscape for India...

Page:10/770 Total number of articles:23098: [First][<<] [8] [9] [10] [11] [12] [>>] [End]